Tri Chemical Laboratories Inc. (TYO:4369)
Japan · Delayed Price · Currency is JPY 3,800.00
+285.00 (8.11%)
Jun 15, 2026, 3:30 PM JST
Tri Chemical Laboratories Cash Flow Statement
Financials in millions JPY. Fiscal year is February - January.
Millions JPY. Fiscal year is Feb - Jan.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Net Income | 6,163 | 7,090 | 6,583 | 3,276 | 6,186 | 5,294 |
Depreciation & Amortization | 2,114 | 1,917 | 1,372 | 1,304 | 1,209 | 1,019 |
Loss (Gain) on Equity Investments | -1,309 | -1,277 | -1,309 | -1,036 | -2,409 | -1,936 |
Other Operating Activities | -75.36 | -2,109 | -264 | 1,021 | 2,407 | -363 |
Change in Accounts Receivable | 15.13 | -1,274 | -1,180 | 550 | -656 | 23 |
Change in Inventory | -1,436 | -1,878 | -1,950 | -1,260 | -584 | -533 |
Change in Accounts Payable | -93.72 | 1,458 | 748 | -713 | 511 | 123 |
Change in Other Net Operating Assets | -496.51 | -132 | -325 | -170 | -272 | 11 |
Operating Cash Flow | 4,882 | 3,795 | 3,675 | 2,972 | 6,392 | 3,638 |
Operating Cash Flow Growth | 110.79% | 3.26% | 23.65% | -53.50% | 75.70% | 74.07% |
Capital Expenditures | -7,915 | -6,286 | -3,069 | -1,739 | -1,530 | -881 |
Cash Acquisitions | -718.08 | -718 | -30 | - | - | - |
Sale (Purchase) of Intangibles | -18.36 | -48 | -14 | -41 | -26 | -50 |
Investment in Securities | -1.2 | -1 | -2 | -1 | -1 | -1 |
Other Investing Activities | -0 | -1 | -1 | - | - | - |
Investing Cash Flow | -8,652 | -7,054 | -3,116 | -1,781 | -1,557 | -932 |
Long-Term Debt Issued | - | 3,000 | 200 | - | - | 500 |
Total Debt Issued | 5,400 | 3,000 | 200 | - | - | 500 |
Short-Term Debt Repaid | - | - | - | - | - | -580 |
Long-Term Debt Repaid | - | -654 | -737 | -785 | -961 | -615 |
Total Debt Repaid | -773.64 | -654 | -737 | -785 | -961 | -1,195 |
Net Debt Issued (Repaid) | 4,626 | 2,346 | -537 | -785 | -961 | -695 |
Issuance of Common Stock | - | - | - | - | - | 4,909 |
Repurchase of Common Stock | -0.24 | - | - | - | - | - |
Common Dividends Paid | -1,136 | -1,136 | -974 | -973 | -649 | -531 |
Other Financing Activities | -0 | -122 | -109 | -100 | -93 | -89 |
Financing Cash Flow | 3,490 | 1,088 | -1,620 | -1,858 | -1,703 | 3,594 |
Foreign Exchange Rate Adjustments | 86.22 | 11 | 3 | 28 | -27 | 35 |
Miscellaneous Cash Flow Adjustments | 0 | 1 | - | -1 | -2 | - |
Net Cash Flow | -193.28 | -2,159 | -1,058 | -640 | 3,103 | 6,335 |
Free Cash Flow | -3,032 | -2,491 | 606 | 1,233 | 4,862 | 2,757 |
Free Cash Flow Growth | - | - | -50.85% | -74.64% | 76.35% | - |
Free Cash Flow Margin | -12.22% | -10.43% | 3.21% | 10.96% | 35.22% | 23.82% |
Free Cash Flow Per Share | -93.30 | -76.65 | 18.65 | 37.94 | 149.61 | 85.05 |
Cash Interest Paid | 50.54 | 34 | 23 | 23 | 28 | 32 |
Cash Income Tax Paid | 1,630 | 2,109 | 653 | 1,520 | 1,518 | 1,041 |
Levered Free Cash Flow | -5,926 | -1,288 | -273.38 | -1,047 | 778.13 | 1,870 |
Unlevered Free Cash Flow | -5,894 | -1,267 | -259 | -1,033 | 795.63 | 1,889 |
Change in Working Capital | -2,011 | -1,826 | -2,707 | -1,593 | -1,001 | -376 |